Veit Rohde
The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors.
Yang Y, Zeitlberger A, Neidert M, Staartjes V, Broggi M, Zattra C, Vasella F, Velz J, Bartek J, Fletcher-Sandersjöö A, Förander P, Kalasauskas D, Renovanz M, Ringel F, Brawanski K, Kerschbaumer J, Freyschlag C, Jakola A, Sjåvik K, Solheim O, Schatlo B, Sachkova A, Bock H, Hussein A, Rohde V, Broekman M, Nogarede C, Lemmens C, Kernbach J, Neuloh G, Krayenbühl N, Ferroli P, Regli L, Bozinov O, Stienen M. The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors. Brain Spine 2021; 1:100304.
Oct 21, 2021The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors.
Oct 21, 2021Brain Spine 2021; 1:100304
Yang Yang, Zeitlberger Anna M, Neidert Marian C, Staartjes Victor E, Broggi Morgan, Zattra Costanza Maria, Vasella Flavio, Velz Julia, Bartek Jiri, Fletcher-Sandersjöö Alexander, Förander Petter, Kalasauskas Darius, Renovanz Mirjam, Ringel Florian, Brawanski Konstantin R, Kerschbaumer Johannes, Freyschlag Christian F, Jakola Asgeir S, Sjåvik Kristin, Solheim Ole, Schatlo Bawarjan, Sachkova Alexandra, Bock Hans Christoph, Hussein Abdelhalim, Rohde Veit, Broekman Marike L D, Nogarede Claudine O, Lemmens Cynthia M C, Kernbach Julius M, Neuloh Georg, Krayenbühl Niklaus, Ferroli Paolo, Regli Luca, Bozinov Oliver, Stienen Martin N
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)
Schaller K, Finkenstädt S, Dan-Ura H, Ferrari A, Bernays R, Eisenring C, Maduri R, Mostaguir K, Kulcsar Z, Maldaner N, Woernle C, Starnoni D, Z'Graggen W, Gasche Y, Sarrafzadeh A, Jakob S, Bijlenga P, Keller E, Raabe A, Beck J, Guzman R, Mariani L, Landolt H, Hildebrandt G, Levivier M, Regli L, Baumann F, Corniola M, Gralla J, Diepers M, Nevzati E, D Alonzo D, Reinert M, Marbacher S, Bervini D, Burkhardt J, Daniel R, Zumofen D, Smoll N, Fandino J, Fathi A, Stienen M, Fung C, Ahlborn P, Mendes Pereira V, Roethlisberger M, Goldberg J, Schöni D, Rohde V, Robert T, Sailer M, Perren F, Venier A, Woernle K, Weyerbrock A, Remonda L, Kerkeni H, Seule M, Schatlo B. Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS). Stroke 2020; 52:344-347.
Dec 4, 2020Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)
Dec 4, 2020Stroke 2020; 52:344-347
Schaller Karl, Finkenstädt Sina, Dan-Ura Hiroki, Ferrari Andrea, Bernays René, Eisenring Christian, Maduri Rodolfo, Mostaguir Khaled, Kulcsar Zsolt, Maldaner Nicolai, Woernle Christoph, Starnoni Daniele, Z'Graggen Werner, Gasche Yvan, Sarrafzadeh Asita, Jakob Stephan M, Bijlenga Philippe, Keller Emanuela, Raabe Andreas, Beck Jürgen, Guzman Raphael, Mariani Luigi, Landolt Hans, Hildebrandt Gerhard, Levivier Marc, Regli Luca, Baumann Fabian, Corniola Marco, Gralla Jan, Diepers Michael, Nevzati Edin, D Alonzo Donato, Reinert Michael, Marbacher Serge, Bervini David, Burkhardt Jan-Karl, Daniel Roy Thomas, Zumofen Daniel, Smoll Nicolas R, Fandino Javier, Fathi Ali R, Stienen Martin N, Fung Christian, Ahlborn Peter, Mendes Pereira Vitor, Roethlisberger Michel, Goldberg Johannes, Schöni Daniel, Rohde Veit, Robert Thomas, Sailer Martin, Perren Fabienne, Venier Alice, Woernle Kerstin, Weyerbrock Astrid, Remonda Luca, Kerkeni Hassen, Seule Martin, Schatlo Bawarjan
Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery
Staartjes V, Schatlo B, Sachkova A, Bock H, Hussein A, Rohde V, Broekman M, Nogarede C, Lemmens C, Kernbach J, Neuloh G, Bozinov O, Krayenbühl N, Sarnthein J, Ferroli P, Regli L, Stienen M, Solheim O, Sjåvik K, Broggi M, Zattra C, Vasella F, Velz J, Schiavolin S, Serra C, Bartek J, Fletcher-Sandersjöö A, Förander P, Kalasauskas D, Renovanz M, Ringel F, Brawanski K, Kerschbaumer J, Freyschlag C, Jakola A, FEBNS. Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery. J Neurosurg 2020:1-8.
Jun 12, 2020Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery
Jun 12, 2020J Neurosurg 2020:1-8
Staartjes Victor E, Schatlo Bawarjan, Sachkova Alexandra, Bock Hans Christoph, Hussein Abdelhalim, Rohde Veit, Broekman Marike L D, Nogarede Claudine O, Lemmens Cynthia M C, Kernbach Julius M, Neuloh Georg, Bozinov Oliver, Krayenbühl Niklaus, Sarnthein Johannes, Ferroli Paolo, Regli Luca, Stienen Martin N., Solheim Ole, Sjåvik Kristin, Broggi Morgan, Zattra Costanza Maria, Vasella Flavio, Velz Julia, Schiavolin Silvia, Serra Carlo, Bartek Jiri, Fletcher-Sandersjöö Alexander, Förander Petter, Kalasauskas Darius, Renovanz Mirjam, Ringel Florian, Brawanski Konstantin R, Kerschbaumer Johannes, Freyschlag Christian F, Jakola Asgeir S, FEBNS
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Schäfer N, Proescholdt M, Steinbach J, Weyerbrock A, Hau P, Grauer O, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch M, Uhl M, Grau S, Hänel M, Schnell O, Krex D, Vajkoczy P, Tabatabai G, Mack F, Schaub C, Tzaridis T, Nießen M, Kebir S, Leutgeb B, Urbach H, Belka C, Stummer W, Glas M, Herrlinger U. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol 2018; 20:975-985.
Jun 18, 2018Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Jun 18, 2018Neuro Oncol 2018; 20:975-985
Schäfer Niklas, Proescholdt Martin, Steinbach Joachim P, Weyerbrock Astrid, Hau Peter, Grauer Oliver, Goldbrunner Roland, Friedrich Franziska, Rohde Veit, Ringel Florian, Schlegel Uwe, Sabel Michael, Ronellenfitsch Michael W, Uhl Martin, Grau Stefan, Hänel Mathias, Schnell Oliver, Krex Dietmar, Vajkoczy Peter, Tabatabai Ghazaleh, Mack Frederic, Schaub Christina, Tzaridis Theophilos, Nießen Michael, Kebir Sied, Leutgeb Barbara, Urbach Horst, Belka Claus, Stummer Walter, Glas Martin, Herrlinger Ulrich
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Schaub C, Kebir S, Junold N, Hattingen E, Schäfer N, Steinbach J, Weyerbrock A, Hau P, Goldbrunner R, Nießen M, Mack F, Stuplich M, Tzaridis T, Bähr O, Kortmann R, Schlegel U, Schmidt-Graf F, Rohde V, Braun C, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Herrlinger U, Glas M. Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol 2018; 144:1581-1589.
May 28, 2018Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
May 28, 2018J Cancer Res Clin Oncol 2018; 144:1581-1589
Schaub Christina, Kebir Sied, Junold Nina, Hattingen Elke, Schäfer Niklas, Steinbach Joachim P, Weyerbrock Astrid, Hau Peter, Goldbrunner Roland, Nießen Michael, Mack Frederic, Stuplich Moritz, Tzaridis Theophilos, Bähr Oliver, Kortmann Rolf-Dieter, Schlegel Uwe, Schmidt-Graf Friederike, Rohde Veit, Braun Christian, Hänel Mathias, Sabel Michael, Gerlach Rüdiger, Krex Dietmar, Belka Claus, Vatter Hartmut, Proescholdt Martin, Herrlinger Ulrich, Glas Martin
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Herrlinger U, Kortmann R, Mehdorn M, Tüttenberg J, Mayer-Steinacker R, Fietkau R, Brehmer S, Mack F, Stuplich M, Kebir S, Kohnen R, Dunkl E, Leutgeb B, Proescholdt M, Pietsch T, Urbach H, Belka C, Stummer W, Gerlach R, Vajkoczy P, Schäfer N, Steinbach J, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, Rohde V, Ringel F, Schlegel U, Sabel M, Ronellenfitsch M, Uhl M, Maciaczyk J, Grau S, Schnell O, Hänel M, Krex D, Glas M. Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J Clin Oncol 2016; 34:1611-9.
Mar 14, 2016Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Mar 14, 2016J Clin Oncol 2016; 34:1611-9
Herrlinger Ulrich, Kortmann Rolf-Dieter, Mehdorn Maximilian, Tüttenberg Jochen, Mayer-Steinacker Regine, Fietkau Rainer, Brehmer Stefanie, Mack Frederic, Stuplich Moritz, Kebir Sied, Kohnen Ralf, Dunkl Elmar, Leutgeb Barbara, Proescholdt Martin, Pietsch Torsten, Urbach Horst, Belka Claus, Stummer Walter, Gerlach Rüdiger, Vajkoczy Peter, Schäfer Niklas, Steinbach Joachim P, Weyerbrock Astrid, Hau Peter, Goldbrunner Roland, Friedrich Franziska, Rohde Veit, Ringel Florian, Schlegel Uwe, Sabel Michael, Ronellenfitsch Michael W, Uhl Martin, Maciaczyk Jaroslaw, Grau Stefan, Schnell Oliver, Hänel Mathias, Krex Dietmar, Glas Martin